Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Now + 818%... lol. How far do you expect this to go, John? I'm not particularly sophisticated but I start to get pretty nervous when I see a RSI of 84+.
Wow! No earnings last quarterly??
I loaded MOXC in early Oct. @ $1.18... Up 706%
Filters:
52 Week Highs
$5 - $20 Stocks
VRS
Loading...
Loading...
17.16 +14.32% 788.0k 220.1k Neutral 6 Firms
MOXC
Loading...
Loading...
9.61 +24.74% 4,955.6k 1,390.3k -- --
DBI
Loading...
Loading...
18.50 +6.41% 1,106.4k 1,763.8k Bearish 7 Firms
CGA
Loading...
Loading...
16.57 +6.19% 175.8k 187.3k -- --
DRN
Loading...
Loading...
18.11 +5.60% 512.0k 419.5k -- -
-
RFP
Loading...
Loading...
15.12 +6.70% 750.8k 782.7k -- --
ABR
Loading...
Loading...
17.23 +5.13% 2,290.5k 1,362.4k Bullish 5 Firms
GT
Loading...
Loading...
19.34 +4.17% 5,562.9k 4,482.4k Neutral 8 Firms
TILE
Loading...
Loading...
14.44 +5.32% 208.2k 370.1k Neutral 7 Firms
GPK
Loading...
Loading...
19.45 +3.82% 1,612.6k 3,019.8k Bullish 7 Firms
DVN
Loading...
Loading...
05/11/2021 - Bulls are fueling up on this energy play.
BILI
Loading...
Loading...
05/11/2021 - Investors should take caution ahead of earnings.
HOL
Loading...
Loading...
Continuation Wedge (Bullish)
HESM
Loading...
Loading...
Continuation Diamond (Bullish)
WPM
Loading...
Loading...
Head and Shoulders Bottom
UGRO
Loading...
Loading...
Diamond Bottom
KL
Loading...
Loading...
Head and Shoulders Bottom
DIS
Loading...
Loading...
Head and Shoulders Top
RLJ
Loading...
Loading...
Head and Shoulders Top
ST
Loading...
Loading...
Head and Shoulders Top
INN
Loading...
Loading...
Head and Shoulders Top
AXON
Loading...
Loading...
Megaphone Top
Senate Majority Leader Chuck Schumer says he’s 'ready to move on federal marijuana reform.'
https://www.vox.com/2021/4/3/22365699/new-york-legalizes-marijuana-schumer-wants-federal-reform
Hey John, you have brought me some nice finds so I would like to return the favour. Victory Square Technologies is an incubator for small companies to grow in a support network before being spun out as stand alone companies. The cool thing about that, VS investors get shares in the new company. Check it out and good luck!
https://investorshub.advfn.com/Victory-Square-Technologies-Inc-VSQTF-31146/
BUY
TerrAscend Reports 2020 Financial Results and Raises Full Year 2021 Guidance
03/23/2021
Canada NewsWire
-- Full Year 2020 Net Sales increased 134% year-over-year to $198 million
-- Q4 Net Sales increased 152% year-over-year and 28% quarter-over-quarter to $65 million
-- Q4 Adjusted EBITDA1 increased 46% quarter-over-quarter to $26 million and Adjusted EBITDA margin increased to 40% from 35% in Q3
-- Ended 2020 with $75 million of cash, mainly driven by positive cash from operations, and subsequently raised $224 million in an oversubscribed non-brokered private placement
-- Converts guidance to US dollars and raises full year 2021 guidance for Net Sales to exceed USD $290 million and Adjusted EBITDA to exceed USD $122 million, both exceeding the high end of previously announced guidance ranges1,4
NEW YORK and TORONTO, March 23, 2021 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today reported financial results for its fourth quarter and year ending December 31, 2020.
Fourth Quarter 2020 Financial Highlights
(Unless otherwise stated, results are in Canadian dollars)
Net Sales of $65 million compared to $51 million in Q3 2020, an increase of 28%.
Adjusted Gross Margin2 increased to 60% compared to 59% in Q3 2020.
Adjusted EBITDA1 increased to $26 million compared to $18 million in Q3 2020.
Adjusted EBITDA1 Margin increased to 40% compared to 35% in Q3 2020.
Cash Flow From Operations of $24 million compared to $0 in Q3 2020.
Full Year 2020 Financial Highlights
(Unless otherwise stated, results are in Canadian dollars)
Net Sales increased 134% to $198 million compared to $85 million in 2019.
Adjusted Gross Margin2 increased to 56% from 4% in 2019.
Adjusted EBITDA1 of $60 million compared to a loss of $27 million in 2019.
Adjusted EBITDA1 Margin of 30% compared to negative 31% in 2019.
Cash Flow From Operations of $33 million compared to a loss of $48 million in 2019.
Management Commentary
"In Q4, we drove strong revenue growth, margin expansion and cash generation by focusing on operational excellence, disciplined cost control and effective allocation of capital," said Jason Wild, Executive Chairman of TerrAscend. "I'm pleased to see how our team has executed in the quarter."
Mr. Wild added, "Looking at our growth plans for 2021, we are well positioned to continue our momentum. The business is firing on all cylinders and we are only now just beginning to realize the benefits of our recently completed investments. Sales from facility expansions in Pennsylvania, New Jersey, and California are just starting to come to market, our acquisition in Maryland is expected to close imminently, and two additional retail stores are set to open in New Jersey."
Fourth Quarter 2020 Operational Highlights
Commenced sales from newly expanded State Flower cultivation facility in California
Realized first sales from 25% capacity expansion in Pennsylvania (in addition to the 3x expansion in Q1 2020)
Closed on US$120 million term loan secured by Ilera business in Pennsylvania
Closed on US$20 million loan from Canopy Growth to the Company's Arise Bioscience division
Appointed Ed Schutter to its Board of Directors
Announced expansion of U.S. footprint via acquisition of Maryland Based Grower Processor
Opened fifth California Apothecarium dispensary in Capitola
Received Permit to dispense medical cannabis at first New Jersey dispensary in Phillipsburg
Subsequent Events
Completed second phase of New Jersey 140,000 sq ft cultivation and manufacturing facility
Received permit in New Jersey allowing for processing, extraction and manufacturing of cannabis products
Raised $224 million in an oversubscribed non-brokered private placement in January 2021
Agreed to settlement and termination of offtake agreement with Pharmhouse for an immaterial amount
Adjusted Gross Profit, Adjusted EBITDA, and Adjusted Net Income are Non-IFRS measures. Please see discussion and reconciliation of Non-IFRS measures below.
Adjusted Gross profit and margin exclude $3 million of one-time non-cash inventory impairment in our Canadian operations.
Q4 and FY2020 Adjusted net income is equal to Net income / (loss), excluding two non-cash and non-recurring items which include the impact of net increase in fair value of warrant and derivative liability of $124 million and the revaluation of contingent consideration of $5 million, predominantly attributable to the Ilera acquisition. Q3 2020 Adjusted Net Income is equal to Net income / (loss), excluding two non-cash and non-recurring items which include the impact of net increase in fair value of warrant and derivative liability of $22 million and the revaluation of contingent consideration of $8 million, predominantly attributable to the Ilera acquisition. Adjusted Net Income was Not Reported (NR) in Q4 and FY 2019.
Beginning in Q1 2021 the Company anticipates reporting financial results in US dollars. Conversion of previous guidance in Canadian dollars uses November 19th, 2020 CAD/USD FX rate of 1.3082 (prevailing rate at the time guidance was introduced) and corresponds to previous guidance of C$360-380 million in Net Sales and C$140-160 million of Adjusted EBITDA.
Net Sales increased 152% to $65 million in the fourth quarter of 2020, as compared to $26 million in the fourth quarter of 2019. Net Sales increased 28% sequentially. The Company continued to expand organically through an increase in cultivation capacity in Pennsylvania and California, the first sales into the New Jersey market, the continued growth and ramp-up at its three retail stores in Pennsylvania as well as two new store locations in California.
Gross margin, before gain on fair value of biological assets, was 55% in the fourth quarter of 2020. Adjusted gross margin, excluding inventory impairment in Canada, a one-time non-cash item, was 60% in the fourth quarter of 2020 compared to 59% in the third quarter of 2020. The sequential improvement in adjusted gross margin is the result of higher mix as well as improved yields and lower cost per pound from the Pennsylvania operations.
G&A expense was $15 million, representing 23% of Net Sales in the fourth quarter of 2020, a reduction from 27% of Net Sales in the third quarter of 2020. This strong leverage is a result of tight control of costs combined with continued robust revenue growth.
Adjusted EBITDA was $26 million in the fourth quarter of 2020, compared to $18 million in the third quarter of 2020. Adjusted EBITDA margins expanded sequentially to 40% in the fourth quarter of 2020 from 35% in the third quarter of 2020 driven by improvements in both gross margin and G&A leverage.
Net loss for the fourth quarter of 2020 was $109 million, largely impacted by a net increase in fair value of warrant and derivative liability of $124 million and a revaluation of contingent consideration of $5 million.
Adjusted net income for the fourth quarter of 2020 was $20 million, a positive result for the second time in company history following the $13 million result in the third quarter of 2020.
Cash flow from operations was a positive $24 million in the fourth quarter of 2020 driven by continued ramp in U.S. operations partially offset by income taxes. Resulting cash and cash equivalents were CAD $75 million as of December 31, 2020, compared to CAD $12 million as of December 31, 2019, and CAD $45 million as of September 30, 2020. Also during the quarter, the Company closed on a US $120 million term loan secured by the Ilera Healthcare division and used part of the net proceeds to pay US $106 million towards the final earnout payment for the acquisition of Ilera. The remaining earnout payment of US $30 million was deferred to June 30, 2021 per a separate agreement with the sellers. Subsequent to quarter end, the Company completed an equity offering raising gross proceeds of CAD $224 million, further strengthening an already strong balance sheet.
As of March 23, 2021, total basic shares outstanding on an as converted basis were approximately 232 million. Fully diluted shares outstanding were 313 million, including approximately 178 million common shares, 15 million common share equivalent preferred shares, 39 million exchangeable non-voting shares, and 81 million warrants and options. The warrants and options had a weighted average strike price of $4.84.
2021 Outlook
TerrAscend is raising full year 2021 guidance to exceed the high end of previously communicated ranges. Additionally, the Company is converting guidance into US dollars due to the anticipated change to USD reporting currency from CAD in the first quarter 2021. The Company expects full year 2021 Net Sales to exceed USD $290 million and Adjusted EBITDA to exceed USD $122 million.
TerrAscend's 2021 outlook is driven by the Company's emphasis on organic growth through expansion in high-quality, limited license markets while continuing to maintain tight control on costs.
In Pennsylvania, sales and profits are expected to benefit from the annualization of multiple increases in cultivation capacity completed in 2020.
In New Jersey, sales from the Company's 40,000 square foot greenhouse and 80,000 square foot indoor cultivation facilities are expected to ramp throughout 2021. TerrAscend's Phillipsburg, New Jersey dispensary will achieve its first full quarter of sales in the first quarter of 2021 and the Company plans to open two additional dispensaries in the state in the second quarter and third quarter of 2021.
In California, the Company completed an expansion of its State Flower cultivation facility in late 2020 which is expected to increase annual production capacity of super-premium craft flower by 500%. The Company's California retail footprint continued to expand with the opening of two new Apothecarium locations in Berkeley and Capitola in the second half of 2020. Both locations continue to scale, and the overall business continues to recover from the easing of COVID restrictions in the state.
In Canada, with a newly streamlined and targeted product portfolio and an optimized cost structure, TerrAscend expects to see positive contributions to sales and profit growth in 2021.
Lastly, the Company anticipates becoming a U.S. filer with the United States Securities and Exchange Commission by the end of 2021. Furthermore, the Company is preparing to meet the requirements necessary for its securities to be traded on a national U.S. exchange should such an event become permissible by U.S. law.
Newsletter Update March 19th, 2021
We have now moved into an interesting and choppy investing environment. Previously you could be a blindfolded monkey throwing darts at a stock dartboard and be a winner (no monkeys were harmed in this discussion). Now you actually get to earn your keep. Or you can simply invest in mutual funds, ETF, or index funds and let the “experts” do a little of the work for you. There are a lot of moving pieces, plates in the air at this time.
Fluctuating interest rates
Inflation fears
A recovering economy
Pandemic fears
A new administration
When you look at most stock charts now you will see a new, “choppy” trend. Before it was higher and higher. Now there is plenty of volatility, both higher and lower.
So what do you do? As always, if you are going to invest in a stock, company, sector, or country, you should put in a certain amount of homework. That being said, what are the trends? What is the outlook for the economy moving forward? Which sectors will see the most gains in the next 12 months? Sure I have my thoughts. A wonderful way to play your hunches is to be familiar with bull and bear (inverse) ETF funds. And the leveraged ETF funds, 1X, 2X and 3X.
Personally, I am sticking with what I know best, Cannabis. It helps that the Cannabis industry is healthy, young, and a durable staple in even the most difficult of times like tobacco, pharmaceuticals, and alcohol.
My goal is to identify the MJ stocks that are undervalued, underappreciated. Last summer just about every MJ stone you turned over was good for 50 percent appreciation within 6 months. Now that the MJ landscape has been scoured over for hidden gems, it is much more difficult to identify companies that are solid, undervalued, and have a rosy future.
DISCLAIMER
John Mueller (The Charles Report) is not a licensed financial, income tax advisor, stockbroker, or licensed real estate agent (almost!). All investment/financial opinions expressed by John Mueller are from my personal research and 35 years of investing experience and are intended as educational material only. Although best efforts are made to ensure that all information is accurate and up to date, occasionally unintended errors and misprints may occur. Purchase and sell real estate and stocks at your own risk.
Wow the intro is great. Love picture too, great time ahead !
The TILT PUMP has been initiated. The robots have been activated. IHUB, Reddit, Twitter. Stock Twits next. Looking for RSI 80+.
There are new markets. The headline news. New states legalizing. That is the only reason I can think of.
Many MSO's are going to multi-tier price options. MEDMED has its "red" shake, low-cost option for those who are penny pinchers.
Why do the experts only highlight eastern holdings and msos? I have a hard time understanding it.there are companies who have survived the over supply in Oregon and are making connections in California. Surviving and thriving in a very competitive environment. What do these eastern companies think is going to happen when they have competition from legacy growers? No body has more than about 10% of the california market but those who have a portion of that and thrive will be able to steamroll anyone who is from the east. Right now, any weed is good weed. When the walls come down, it must be stellar or nobody will use it. I am not sure if it is the political climate that limits real discussion or what but it is interesting to watch. Premuim bud will always have a market. Everything else will be commoditized and extracted off shore (likely grown in Columbia or Africa) and used as an ingredient. Think sugar cane.
Ninth Harvest-Affiliated Pennsylvania Dispensary Opens in Whitehall
BY PR Newswire
03/11/2021
PHOENIX, March 11, 2021 /PRNewswire/ -- Harvest Health & Recreation Inc. ( HRVSF ) ("Harvest"), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the opening of a new medical dispensary in Whitehall, Pennsylvania.
Harvest of Whitehall is located at 1809 MacArthur Rd, Whitehall and is open Monday through Saturday from 9:00 am to 7:00 pm and Sunday from 10:00 am to 6:00 pm. Additional Harvest affiliated dispensaries in Pennsylvania are located in Camp Hill, Cranberry Township, Harrisburg, Johnstown, King of Prussia, Reading (two locations), and Scranton.
"We are pleased to open our ninth Harvest-affiliated location in Pennsylvania, one of the fastest-growing medical markets in the U.S.," said Chief Executive Officer Steve White. "We look forward to serving patients and providing quality products at this new location in one of our core markets."
About Harvest Health & Recreation Inc. ( HRVSF )
Headquartered in Tempe, Arizona, Harvest Health & Recreation Inc. is a vertically integrated cannabis company and multi-state operator. Since 2011, Harvest has been committed to expanding its retail and wholesale presence throughout the U.S., acquiring, manufacturing, and selling cannabis products for patients and consumers in addition to providing services to retail dispensaries. Through organic license wins, service agreements, and targeted acquisitions, Harvest has assembled an operational footprint spanning multiple states in the U.S. Harvest's mission is to improve lives through the goodness of cannabis. We hope you'll join us on our journey: https://harvesthoc.com
Facebook: @HarvestHOC
Instagram: @HarvestHOC
Twitter: @HarvestHOC
FFNTF 4Front Ventures Corp
4Front Announces Third Quarter 2020 Results and Business Update
PR Newswire
PHOENIX, Nov. 30, 2020
Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million, 170% year-over-year – Company became cash flow positive from operations in August
Company sale-leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170-180 million and Adjusted EBITDA of $40-50 million
The Company's existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million
PHOENIX, Nov. 30, 2020 /PRNewswire/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company") today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.
Third Quarter 2020 Financial Results Highlights
Systemwide Pro Forma Revenue for the third quarter 2020 increased 18% quarter-over-quarter to $22.3 million
IFRS Sales for the third quarter of 2020 increased by 25% quarter-over-quarter to $12.4 million
Adjusted EBITDA for the third quarter was $3.7 million
Business Updates and Developments
Q3 2020 Systemwide Pro Forma Revenue increased 18% quarter over quarter to $22.3 million. Robust revenue trends continued across the portfolio led by the launch of recreational sales in Massachusetts in the quarter and the re-opening of Mission South Chicago in late July. Washington state experienced record sales in the quarter while increasing prices. The Company achieved positive operating cash flow beginning in the month of August 2020 and is poised to show significant operating leverage in 2021.
Strong balance sheet supports continued growth in 2020 through 2021. As of September 30, 2020, 4Front's balance sheet had cash and equivalents of $8.5 million with total debt of $76.5 million (excluding in-the-money convertible debt of $5.8 million).
On November 23, 2020, the Company closed an oversubscribed bought deal led by Beacon Securities for US$13.2 million. The Company also announced it entered into definitive purchase and sale agreements with an affiliate of Innovative Industrial Properties, Inc., providing for the sale and leaseback of 4Front's cultivation and production facilities in Tumwater, Washington and Georgetown, Massachusetts.
The all-cash sale price of $30 million is on-track to close by mid-December and will be used by the Company to pay down the outstanding senior secured debt obligation to affiliates of Gotham Green Partners.
As of November 30, 2020, pro forma for the close of the pending sale-leaseback transaction and including proceeds from the recently closed bought deal financing, the Company will have approximately $16 million of cash and $43 million of long-term debt due May 2024.
Company is finalizing plans to exponentially expand its cultivation and manufacturing presence in Illinois. The Company has one of 20 cultivation licenses in Illinois that allows for 210,000 square feet of flowering canopy and is currently acquiring acreage for construction of a cultivation facility and state of the art manufacturing facility, adding significant blue sky to its already established presence in Illinois
Final stages in construction of 185,000 square foot manufacturing facility in Commerce, California underway with completion scheduled for Q2 2021. The Company's fully funded state-of-the-art 185,000 square foot manufacturing only facility in Commerce, California is nearing completion and should be ready to serve the $3 billion California cannabis market in Q2 2021.
The project is on target to be completed in April 2021 with the Company planning for the first of its full line of edibles, tinctures and vape products to be on California retail shelves by May 2021.
Cultivation facility expansion completed in Illinois. Massachusetts facility retrofitting enters final phased approach. The Company's expansion at its Elk Grove, Illinois cultivation facility, which will increase the flowering canopy from 3,000 to 9,072 square feet, is substantially completed on time and under budget. The retrofitting of the Company's Georgetown facility is complete and ready for the phased installation of LED lights, which are expected to increase yields by 35 - 50%. In the quarter, weighted average annualized yields from flowering canopy across the portfolio was 319 grams per square foot.
Q4 opening of second Illinois retail location in Calumet City remains on schedule. Construction of the dispensary is substantially completed as the Company is set to open its second Illinois retail location in Calumet City (approximately one mile from the Indiana border) in December 2020. Final inspection is scheduled for December 8 with a Grand Opening currently anticipated on December 15, 2020.
Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170-180 million and Adjusted EBITDA of $40-50 million. This guidance is fully funded and contemplates only current operations including December opening of the Calumet City retail location plus the opening of a Brookline, Massachusetts dispensary and the Commerce production facility in May 2021. This guidance includes facilities scheduled to open in 2021. If such openings are delayed due to Covid-19, guidance could be negatively affected.
Management Commentary
Leo Gontmakher, CEO of 4Front, said, "We are incredibly pleased with our third quarter 2020 results that reflect the Company's laser focus on execution. We have big plans for our platform, but it all starts with operational excellence and delivering to shareholders what we say we are going to deliver. While we have much more to accomplish, the hard work of our team has set the table for what I expect to be an exciting year for our company in 2021.
With 4Front's constant operational improvements and an expected strong year for the cannabis industry overall, we are pleased to provide Covid-qualified initial 2021 guidance of $170-$180 million in Pro Forma Systemwide Revenue and $40-$50 million in Adjusted EBITDA, with the longer-term opportunity in our current geographical footprint upwards of $650 million in revenue and $250 million in EBITDA.
Mr. Gontmakher added, "In addition to the strong fundamentals across our legacy markets, plus an encouraging regulatory environment, we are excited to announce the timing of our entry into California and will soon provide details about our aggressive expansion plans in Illinois, projected to be a multi-billion, medical and adult-use market.
"In summary," said Gontmakher, "achieving robust expansion and sustained profitability through our low-cost production model has proven to be both replicable and scalable across key US cannabis markets positioning 4Front as a major MSO player. With the completion of our bought deal financing, as well as the sale-leaseback transaction, 4Front will end the year with a strong balance sheet providing the financial stability to expand the business in our key target states."
Additional Details
As of the date of the MD&A, there were the equivalent of 534,177,375 Class A Subordinate Voting Shares outstanding when calculated as if all share classes were converted to Subordinate Voting Shares. For further details regarding 4Front's share structure, please see its profile at www.thecse.com.
The Charles Report
Featuring TILT Holdings OTC QX TLLTF
$0.5689
March 9th, 2021
TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation, and production, TILT services brands and cannabis retailers across 35 states in the U.S., as well as Canada, Israel, Mexico, South America, and the European Union. TILT’s core businesses include Jupiter Research, LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing, and cannabis operations Commonwealth Alternative Care, Inc. in Massachusetts and Standard Farms, LLC in Pennsylvania. TILT is headquartered in Phoenix, Arizona.
Outstanding Shares 323,756,294 03/02/2021
TILT Holdings Provides Preliminary Fourth Quarter Results, Operational Highlights, and 2021 Outlook 02/17/2021
Jupiter Q4 2020 revenues return to pre-COVID levels
Standard Farms extraction capacity increased by 100% during Q4 2020
CAC lab and kitchen production capacity increased by 100% during Q4 2020
Projected Preliminary Financial Highlights:
• Q4 2020 revenue is projected to be between $42.2 million and $43.2 million, compared to Q3 2020 revenue of $40.4 million
• Q4 2020 Adjusted EBITDA is projected to be between $2.6 million and $3.6 million, compared to Q3 2020 Adjusted EBITDA of $2.8 million
• Pro-forma Q4 2020 revenue excluding the Company’s former subsidiary, Blackbird, is projected to be between $41.3 million and $42.3 million, compared to Q3 2020 Pro-forma revenue of $39.1 million
• Pro-forma Q4 2020 Adjusted EBITDA excluding the Company’s former subsidiary, Blackbird, is projected to be between $4.6 million and $5.6 million, compared to Q3 2020 Pro-forma Adjusted EBITDA of $5.4 million
• $7.4 million cash balance as of Dec. 31, 2020, compared to $4.3 million at Sept. 30, 2020
Fourth Quarter 2020 Operational Highlights:
• Jupiter Research LLC’s (“Jupiter”) power supply revenue doubled from Q3 2020 to Q4 2020; revenues during the quarter reached pre-COVID levels
• Commonwealth Alternative Care, Inc.’s (“CAC”) lab and kitchen production capacity increased 100% during the quarter; cultivation expansion approved October 2020 planted during Q4 2020 and expected to yield the first harvest in March 2021
• Standard Farms, LLC (“Standard Farms”) doubled extraction processing capacity during the quarter; introduced six new manufactured product offerings
Full Year 2021 Outlook:
2021 strategic initiatives fully funded; outlook not expected to require significant CAPEX or M&A.
• Revenue range of $205 million to $210 million
• Adjusted EBITDA range of $30 million to $32 million
TILT Holdings Reports Third Quarter 2020 Financial Results Including Record Adjusted EBITDA, Enters into Definitive Agreement for the Sale of Blackbird Subsidiary 11/18/2020
Revenue of $40.4 million, driven in part by a 24% sequential increase in the cannabis segment compared to the second quarter of 2020
Gross margin of 30.3%, a 193-basis point improvement from the second quarter of 2020, driven by margin expansion in the cannabis segment
Record adjusted EBITDA of $2.8 million, an increase of 134% from the second quarter of 2020
Upon closing, Blackbird divestiture reduces cash burn, improves third quarter 2020 adjusted EBITDA by 96% on a Pro-forma basis
Financial Summary for the Quarter Ended September 30, 2020
• Revenue of $40.4 million, a 5% increase from the second quarter of 2020 and a decline of 12% from the prior-year period.
• Gross margin1 of 30.3%, up 193 basis points (“bps”) from the second quarter of 2020 and up 8 bps from the prior-year period.
• Positive adjusted EBITDA for the third consecutive quarter at $2.8 million, a 134% increase from the second quarter of 2020, and a 3% increase from the prior-year period.
• Excluding the impact of Blackbird, Pro-forma adjusted EBITDA of $5.4 million for the second quarter of 2020 and $12.7 million year to date.
• Net loss ($4,617,000)
• Cash and cash equivalents of $4.3 million, a decline from the previous quarter $10.5 million as of June 30, 2020 due, in part, to additional inventory required to fulfill increasing orders.
Welcome to “Stock Market Investing!”
www.meetup.com
We get together on ZOOM, every other Saturday at 5:00pm.
https://www.meetup.com/stock-market-investing/events/rwhkdsycccbfc/
Please join me as well on a free discussion board website, Investors HUB.
Cannabis Investment Club
https://investorshub.advfn.com/Cannabis-Investment-Club-33161/
JohnCM Investment Corner
https://investorshub.advfn.com/JohnCM-Investment-Corner-37729/
My Stock Investment Newsletter
https://docs.google.com/document/d/1e37ezUfDkZ7TSiEwRStGnoYqGSzWXskkMfcpMg-9KVo/edit?usp=sharing
The Charles Report
JohnCM
DISCLAIMER
John Mueller is not a licensed financial, income tax advisor, stockbroker, or licensed real estate agent (almost!). All investment/financial opinions expressed by John Mueller are from my personal research and 35 years of investing experience and are intended as educational material only. Although best efforts are made to ensure that all information is accurate and up to date, occasionally unintended errors and misprints may occur. Purchase and sell real estate and stocks at your own risk.
Ha ha, very nice observations there and yeah, followed John almost since inception here - noticed the 'straight talk' in a field of landmines, lol.. Don't get me wrong, think there is a place for all matters of opinion (how else is one to poke those sensibilities ;).
Some of Mine have recently been harpooned!, lol - wankers ;).
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162398681
So many thinks to be thunk so little time :) I would love to have coffee or a canna bev sometime. You dive deep. I enjoy your posts and John is amazing. Everyone so generous here. I believe if we can learn one thing, we can learn two things we just need to be motivated.
John, thanks for all your efforts on the newsletters. Lots of great information for investors/traders on any level.
Best regards.
STOCK INVESTMENT NEWSLETTER
March 6th, 2021 no.105
ZOOM meetings 5:00pm PST Saturdays every 2 weeks
Next meeting March 13th
https://www.meetup.com/stock-market-investing/
https://investorshub.advfn.com/JohnCM-Investment-Corner-37729/
https://investorshub.advfn.com/Cannabis-Investment-Club-33161/
John’s portfolio Friday -0.03% Monday +6.86%
+50.11% (unrealized gains) Portfolio
Investment Rate of Return +67.53%
EMERGENCY
INDUS HOLDINGS INDXF
$1.92(SOLD)
BUY TILT TLLTF
$0.545 (now $0.50)
Trading Secret #4
This technique has taken me 35 years to get right.
Download the smartphone app "Stocks Alert."
Pick a percentage of your total shares in your position that you will use to trade around your core position. 33 percent?
Set the RSI(14) alert to 80.
When 80 is triggered, sell 33 percent.
Buyback at 60 and either pocket the cash difference or buy back more shares than you sold.
INTEREST RATES
Hmmm, how do interest rates affect me? And why do they increase? (Or rather why does the FED increase interest rates?) Is it simply supply and demand? In a way, yes. The primary motivation for the increase in interest rates is to keep inflation from rising. What increases inflation? Demand. What is the result of inflation? Higher price tags for everything you spend your money on. Services, goods, travel, food, housing, fuel, clothing, luxury items, etc.
So, if the FED is keeping an eye on inflation, why do I need to pay attention to interest rates? All depends. Do you have any investments in Real Estate or in the Stock Market? Hopefully, by now, most folks have converted their ARM mortgage into fixed rate. In that case, a higher interest rate on your mortgage is not a worry.
How about the stock market? You would think that a recovering economy would help buoy the markets, right? Yes, to a limit. The market is typically 6 months forward looking. So, your stocks have already priced in where economists expect the U.S. to be on August 1st, 2021. When interest rates increase, so do the number of alternative, safer vehicles to earn interest/dividends/capital gains on your stock market investment. When there are more, safer alternatives, they are fewer buyers of company stock as an investment.
I should add here, as a rule, precious metals should take up a 5% position in your portfolio. Individual miners, ETF (long/inverse/ leveraged 1X 2X 3X), or simple bullion.
Getting back to the stock market. The markets right now are priced to perfection. Any seismic shift will send the DOW lower. A 10 percent decline is still not out of the equation. Seismic shift? World events i.e., saber rattling from a communist country. Nuclear arms concerns. Higher interest rates. A major setback in the fight against COVID-19, to name a few.
When you see a meaningful increase in interested rates, and as I mentioned earlier, the trend is beginning right now, you want to have a defensive game plan in regard to your stock positions. (Not so much mutual funds. You have professionals baby-sitting those for you). There are a number of ways you can prepare for future pressures on the stock market. Look for sector niches that will benefit from the recovering economy. Use ETF funds for this. Set stop limit orders to protect your gains (you do not want to give them all back). Look to inverse ETF (bear) funds. Precious metals. CASH.
Getting back to Real Estate. I hate to say it BUT the party will not last forever. This is not directed to quality Real Estate agents who always flourish because of their elevated marketing skills and their ability to work well with people. Regardless of the economy, there will always be a housing market. The party I am referring to is the one being thrown by homeowners. When we see interest rates rise, the affordability factor for home buyers is reduced. When real estate is costlier to purchase, this puts a damper on prices and activity. But even with an increase in interest rates homeowners have another “dog that will hunt.” Supply. If there is one house available to purchase and 100 buyers, the price will stay elevated regardless of the mortgage interest rate being offered.
Supply. Supply. Supply. From what I can tell, real estate prices have topped out, regardless of supply, interest rates, the economy the presidency, the Mars landing. What will affect supply? More houses being placed on the market, or fewer buyers? From what I can tell we are going to see an increase, not a decrease, in interested home buyers. The only factor putting pressure on this is the "affordability factor." So now we have to look at new home construction.
Who remembers earlier housing booms that went bust? Do you believe that this will never happen again? We have seen a historical cycle of booms and busts over the last 100 years. Where do you think we are at in this current cycle? We are at the top. What do you do when you are holding an investment and the price is at the top? There are 2 ways of thinking. One is greed. “Hey, things are going so well, why would I want to sell if the price is going up and up and up?” This makes sense, until it does not. Two, the folks who know when to "ring the register." What did Warren Buffet say? "Sell when people are buying (market bubbles, froth, exuberance, greed) and buy when people are selling( fear, panic, sense of loss, herd mentality)."
So, what do you do if you need to buy a house at the market top due to a change in jobs, family events, relocation, or the need for a bigger house? #1. Find a quality Real Estate agent. #2. Get pre-qualified from a lending institution. Ask your Realtor who they work closely with. This is important. #3. Realize that you will have to "settle" on filling out your “wish list” checklist. #4. Be ready to pounce on a home you like the way Tom Brady was ready to pounce on the Chiefs during the Super Bowl. Was Tom Brady prepared? Did he have his "head in the game?" Did he have ALL of his "ducks in a row?" #5. Ask your Realtor about utilizing a "Multiple Offer Playbook." This will list up to 25 techniques that will ensure that you are not missing a thing, and that you are giving your absolute best. #6. Know your limits. i.e., what are you prequalified for in terms of price?
#7. Be comforted in knowing that although, historically, you are paying a high price for your new home, you are also buying the neighborhood, the town, the weather (if you like it), the surrounding amenities and finally, you are moving into a home that you love. All of a sudden, some of these important qualities become "priceless."
Tuesday, Feb 23
Airline, cruise stocks surge to start the week.
Investors can't keep up with economic optimism right now.
On Monday, the re-opening trade was on fire with shares of airlines, cruise lines, and banks all rallying. And this while Wall Street strategists continued raising full-year GDP forecasts as others reiterated calls that consensus estimates are still too conservative.
Which continues to show that for all of the optimism about 2021 that was anticipated by investors last year, folks are still playing catchup.
Travel stocks were the stars of the market show on Monday, with positive earnings commentary from Royal Caribbean (RCL) and an industry-wide upgrade of the airlines from Deutsche Bank analyst Michael Linenberg catalyzing the moves.
Royal Caribbean said pricing for its bookings for the second half of this year are trending higher than 2019, adding that 75% of bookings for 2021 are new reservations. Shares of Royal Caribbean gained 9.5%, while peers Carnival Cruise (CCL) and Norwegian Cruise Lines (NCLH) also rallied more than 5.5%.
Meanwhile, Linenberg's call on the airline industry sent American Airlines (AAL) shares up more than 9% while United (UAL), Delta (DAL), Southwest (LUV), and JetBlue (JBLU) all gained more than 3%.
________________________________________
NEWS!!
2 NEW CANNABIS COMPANIES
VERANO - VRNOF
CHOICE CONSOLIDATION (NO TICKER YET)
VERANO HOLDINGS VRNO (CSE) IPO on Canadian exchange Wednesday, February 17th.
"They said" shares would be available to trade on the OTC in about 3 weeks.
Good news, bad news.
Good news.
When the OTC ticker is available, the volatility of the share price will have modulated with 18 trading days under its belt. So, instead of buying at the initial IPO "pop" only to see the price wane after the initial surge, you will be buying at a "non-pumped" price.
Bad news.
You will miss out on 3 weeks of appreciation IF the markets love this company. For all intents and purposes, they will.
Initial est. valuation $32 US. (Came out around $23 - $24 U.S. $27 - $28 CA)
TRADING
A step-by-step explanation is the best way to illustrate the trading process. The example below is tailored for individual investors, although many of the same principles apply to institutional investors.
1. Investor Selects a Broker-Dealer — In order to execute a trade, an investor must have an account at a FINRA-registered broker-dealer.
2. Investor Makes an Investment Decision — Investment decisions should be based on thorough research on the company and security. For securities that trade on the OTCQX, OTCQB and Pink markets, investors can use www.otcmarkets.com to access the information companies have provided, including trade data and company news and financials to help facilitate an investment decision.
3. Investor Defines the Order — Investors define the order they wish the broker-dealer to handle. The two primary order types are Limit Order and Market Order.
o Limit Orders allow investors to specify the exact price they are willing to accept for a buy or sell order. While Limit Orders are designed to offer more price protection for investors, a Limit Order may not be executed if the price of the security does not reach the price stated in the Limit Order.
o Market Orders direct the broker-dealer to immediately execute either a buy or sell order at the current 'market price' — the best bid or offer.
Investors must decide whether price (Limit Order) or timing/immediacy (Market Order) is more important to them.
4. Broker-Dealer handling of the Order — Once a broker-dealer receives an order, it often goes through the following steps as part of the trading process:
o Execute Trade Internally — Broker-dealers will typically first determine if the order can be executed internally. Internal executions occur if they can 'match' (same prices for a buy and sell order) Limit Orders or if they provide liquidity against their own account. If they are trading for their own account, they generally must give investors the best available quoted price or better at that point in time. This rule is known as Best Execution and is among the regulations discussed in Part 3 - Regulation
o Trade Marketable Order Externally — If the broker-dealer cannot, or chooses not to, execute the trade internally they will attempt to execute the trade with another broker-dealer. OTC Link® ATS provides trading and messaging capabilities, which facilitates the process of ascertaining whether the order is marketable. Marketable orders are orders where the price specified can immediately be executed in the market. Market Orders are, by definition, marketable. Limit Orders are marketable if the limit price is less than or equal to the bid price (for sell orders) or greater than or equal to the ask price (for buy orders) (i.e., execution is at a price better than or equal to the limit price). For example, a customer's Limit Order to buy security ABCD for $30 will only be marketable if the offer/ask price is $30 or less. If the offer price is $30.01 or greater, then the limit order is not marketable and will not be executed. If the order is marketable, the broker-dealer may utilize OTC Link® ATS to negotiate a trade.
o Create/Edit Quote on OTC Link ATS — If the order is not marketable, the broker-dealer may be required to adjust its existing quote to reflect a new price or size. Broker-dealers are only required to update their quote if the price of the order is equal or superior to their existing quote (See FINRA Rule 6460 and Part 3 - Regulation). In many cases, a broker-dealer quote size represents an aggregation of a number of customer orders. Trade Non-Marketable Order Externally - Once a broker-dealer has a quote posted on OTC Link® ATS, they may receive a trade message via OTC Link® ATS from another broker-dealer; as the market changes, a broker-dealer with a standing quote may also initiate a trade message electronically. At that point, the broker-dealer may accept, decline or counter (send a different price or size) the offer to trade. The broker-dealers then negotiate trade price/size, one of the main differences between a trading a security off-exchange and trading a listed security. There is no central system that matches/executes orders for off-exchange traded securities — all trades are agreed upon directly between the broker-dealers. OTC Markets Group's trading platform, OTC Link® ATS, facilitates negotiated trading. Broker-dealers are required to be firm at their quote prices up to the sizes displayed. While broker-dealers may communicate by phone, one of the benefits of OTC Link® ATS is the ability for broker-dealers to trade and message electronically, creating a more efficient trading process.
Exchange Traded Fund (ETF) - Investopedia
An exchange traded fund (ETF) is a basket of securities(stocks) that trade on an exchange, just like a stock. ETF share prices fluctuate all day as the ETF is bought and sold; this is different from mutual funds that only trade once a day after the market closes.
'It’s the toughest time in the restaurant industry ... in the last 30 or 40 years': Celebrity chef Marcus Samuelsson
In anticipation of restaurants opening
**Chains, indoor dining
**ETF pleasure, dining out
**Foodservice delivery
**Supplies and small wares
**Restaurant centric companies i.e., Maître D
**Website "Open Table"
**Bar service
The Biden Presidency
It is not too late to take advantage of our new administration. Think “green.” Cannabis and renewable, clean energy. A new emphasis on climate change, environmental protection, etc.
https://www.greenprophet.com/
Stocks for the “Green Gold Rush”
The Industrial Revolution… The 1980s Computer Boom… The Internet of Things…
Throughout history, we have seen fortunes made, with market leaders rising on the back of new economic tailwinds. And it is not too late to get in on the next possible economic gamechanger sweeping the nation.
Take the potential of the Industrial Revolution and remove the soot-covered cities…
Investing in “green” companies could add some green to your bank account. And we are not just talking green tech—there are companies across sectors that are using sustainable, environmentally conscious principles to decrease their carbon footprint and increase their stock value.
Definitive List of Alternative Energy Equities ETFs
This is a list of all US-traded ETFs that are currently included in the Alternative Energy Equities ETFdb.com Category by the ETF Database staff. Each ETF is placed in a single “best fit” ETFdb.com Category.
ICLN
iShares Global Clean Energy ETF
TAN
Invesco Solar ETF
QCLN
First Trust NASDAQ Clean Edge Green Energy Index Fund
ACES
ALPS Clean Energy ETF
PZD
Invesco Cleantech™ ETF
FAN
First Trust ISE Global Wind Energy Index Fund
PBD
Invesco Global Clean Energy ETF
NRG
SPDR S&P Kensho Clean Power ETF
GRID
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
CANNABIS STOCKS TOP 10
My criteria;
#1. I like to see at least 100M in annual sales.
#2. I like to see an outstanding share number of less than 300M.
#3. The stock must have momentum. Especially right now.
#4. On the way to EBITDA break-even, if not there yet.
#5. Maybe a turnaround story, or legit, right out of the box.
#6. Typically, will be focused on the U.S., not Canada.
#7. For now, will be marijuana only. No hemp.
1) TILT TLLTF HOLD ADD
2) High Tide HITIF HOLD ADD
3) Columbia Care CCHWF HOLD ADD
4) Harvest Health HRVSF HOLD ADD
5) 4Front FFNTF HOLD
6) CRESCO CRLBF SOLD
7) Verano Holdings VRNOF NEW NO POSITION
8) TerrAscend TRSSF NO POSITION
9) AYR Resources AYRWF SOLD
10) Green Thumb GTBIF SOLD
11) HEXO HEXO SOLD
12) Schwazze SHWZ NO POSITION
13) Jushi JUSHF SOLD
14) Trulieve TCNNF NO POSITION
15) INDUS Holdings INDXF SOLD
16) HOLLISTER HSTRF SOLD
17) GrowGeneration GRWG NO POSITION
18) Curaleaf CURLF SOLD
19) TILRAY TLRY SOLD
20) TPCO Holding Inc GRAMF SOLD
Too late to find quality underpriced Cannabis stocks? But even the worst companies are increasing in value because the entire Cannabis sector is doing well.
Looking at the Cannabis SPACS right now. GRAMF and soon to come, Choice Consolidation.
EBITDA
What Are Earnings Before Interest, Taxes, Depreciation, and Amortization?
EBITDA, or earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances. EBITDA, however, can be misleading because it strips out the cost of capital investments like property, plant, and equipment.
This metric also excludes expenses associated with debt by adding back interest expense and taxes to earnings. Nonetheless, it is a more precise measure of corporate performance since it is able to show earnings before the influence of accounting and financial deductions.
Simply put, EBITDA is a measure of profitability. While there is no legal requirement for companies to disclose their EBITDA, according to the U.S. generally accepted accounting principles (GAAP), it can be worked out and reported using the information found in a company's financial statements.
The earnings, tax, and interest figures are found on the income statement, while the depreciation and amortization figures are normally found in the notes to operating profit or on the cash flow statement. The usual shortcut to calculate EBITDA is to start with operating profit, also called earnings before interest and tax (EBIT) and then add back depreciation and amortization.
CANNABIS STOCK PICKs OF THE WEEK
High Tide
Indus Holdings
TILT
Hollister
4Front
Harvest Health
(It is getting harder to find undervalued MJ stocks)
Next quarter’s earnings release should boost both HEXO and Harvest Health
Bloomberg
With New Lobbying Clout, Big Pot Has Arrived: Cannabis Weekly
Big Alcohol and Big Tobacco have garnered a formidable reputation in the lobbying arena over the years. Big Pot is now looking for a piece...
Why Cannabis?
I have followed the Cannabis sector for over 7 years. There are now 3 solid reasons to look at the Cannabis sector in regard to your investment portfolio.
Number one - MOMENTUM
States are falling like dominos legalizing marijuana for recreational use. Throw in the Biden win, and this is a trend that cannot be stopped.
Number two - PROFITABILITY
cannabis companies are reporting net profitable quarters. Look what happened to Tesla when they reported their first profitable quarter. Two companies of note, Trulieve and Cresco.
Number three - The ARBITRAGE play (Buy Out)
American companies, wanting to partner with or purchase Cannabis companies, have to stay at arm’s length from Cannabis companies because marijuana is a schedule one substance (the most dangerous), and it is illegal federally.
When the fed loosens its grip and/or marijuana is legalized federally, BIG business will rush in to swoop up already established Cannabis companies at a premium. BIG tobacco, BIG liquor, BIG beverage, BIG pharmaceutical, BIG leisure, retail grocer, health food and nutritional companies.
BIG TOBACCO
BIG LIQUOR
BID RETAIL
BIG NUTRITION
BIG PHARMA
BIG BEVERAGE
BIG POT
MJ tailwinds
#1. State dominos are falling for legalization. Arizona. Florida next?
#2. First time House votes approvingly on legalizing marijuana.
#3. President and vice president-elect Biden and Harris are pro-cannabis.
#4. U.S. MSO's (Multi-state operators) are starting to report net profitable quarters.
#5. MOMO (momentum).
#6. Democrat control of the Senate.
How to Use Index Futures - Investopedia
The rise or fall in index futures outside of normal market hours is often used as an indication of whether the stock market will open higher or lower the next day. When index futures prices deviate too far from fair value, arbitrageurs deploy buy and sell programs in the stock market to profit from the difference.
FUTURES 2/15 Begin at 3:00pm on Sunday for Monday’s open
DOW +/-
NASDAQ +/-
Check on mobile app CNBC!
BEST REFERENCES
1. Smartphone app – “Yahoo Finance”
https://play.google.com/store/apps/details?id=com.yahoo.mobile.client.android.finance&hl=en
2. Investor Business Daily https://www.investors.com/
3.
4. www.otcmarkerts.com
5.
6. https://www.stockscores.com/charts
7.
8. Smartphone app – “Stocks Alert” by Milhomens Apps
https://appgrooves.com/android/cat.obiols.milhomens.BorsaValors/stock-alert-formula/milhomens-apps
9. Investors HUB https://investorshub.advfn.com/
Cannabis Investment Club
https://investorshub.advfn.com/Cannabis-Investment-Club-33161/
JohnCM Investment Corner
https://investorshub.advfn.com/JohnCM-Investment-Corner-37729/
I have known of this following discipline for 30+ years, but rarely used it, UNTIL NOW!
"Trading around a core position"
You own 100 shares of ABC Inc.
You have the smartphone app STOCKS ALERT setup on your phone with your portfolio. All of your stocks are monitored for RSI(14) oversold (30) and overbought (70) levels. As well as (20), (80), (60).
When ABC Inc. flashes the RSI(14) 80 threshold has been reached, I sell 33 shares. When the stock flashes (60), I either, pocket the extra CASH, or buy 33 plus shares.
This Stock Investment Newsletter is free to enjoy.
I also have available my “live” version of the newsletter that includes my “real time” trades (buys and sells), portfolio positions and immediate “stock tips.”
If you wait 7 days to act on one of my recommendations, that is an eternity of time in the investment world. Stocks can move 5%, 10% or more, in a single day, let alone 5 trading days.
To take a peek at my “live” newsletter version, click here
https://johncmueller.com/stock-investment-newsletter/
DISCLAIMER
John Mueller is not a licensed financial, income tax advisor, stockbroker, or licensed real estate agent (almost!). All investment/financial opinions expressed by John Mueller are from personal research and 35 years investing experience and are intended as educational material only. Although best efforts are made to ensure that all information is accurate and up to date, occasionally unintended errors and misprints may occur. Purchase and sell real estate and stocks at your own risk.
GM John...I'm Looking for pros/cons on MJ, RE, EV & BTC ETF's...is it a good time to take profits and lock in a few ETF's?...thanks!
john always appreciate your thoughts and help.thanx much
Nicely said hg,.. and/or like the oldy/goldy,
"I suppose it is tempting, if the only tool you have is a hammer, to treat everything as if it were a nail."[2]
https://en.wikipedia.org/wiki/Law_of_the_instrument
Similarly,.. [and this is where our host, well versed in these things staying up late burning the midnight candlesticks with a good head on da shoulders for us..lol https://www.google.com/search?sxsrf=ALeKk00QqAh9NwW2hq3OF4UZqmTW0nIgQQ:1615024308828&source=univ&tbm=isch&q=technical+analysis+patterns&client=firefox-b-d&sa=X&ved=2ahUKEwiZp-yxspvvAhWIVs0KHdzDDcoQjJkEegQIBRAB&biw=1280&bih=882 ;] and in psychology;
One reason might lie in the way the perception centers of our brains are structured. The fact is, we seem to spend at least as much time and effort looking for patterns we recognize as we do scanning for the unexpected and new.
Another, .. for example, when offered $50 now instead of $100 in a month, most people will choose the fifty bucks.
https://www.psychologytoday.com/ca/blog/shut-and-listen/201806/humans-cant-plan-long-term-and-heres-why
And yes, you light on morals/values which I believe is getting more airtime as we do (usually necessitated by crisis) once in a while take a glimpse ahead like this recent macro economic lecture series nicely summed up by the kernal: "The price of everything is becoming the value of everything"
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162056007
Money is a tool. A handy tool but what you do with it matters. You can build a house with a hammer or hit someone and cause harm. Same kind of blunt instrument. We do not honour the house built with the hammer, the people who designed it, or the people who live in it....... everybody want closets full of hammers tho. Strange beings we humans.
Almonty Industries Inc. Announces an End-of-Year Christmas Update
12/14/2020
Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / OTCQX: ALMTF / Frankfurt: 1MR) is pleased to announce an end-of-year update.
Almonty Korea Tungsten Sangdong project – After the previously announced execution of the loan agreements, the Company wishes to update the market on its current status. The Monty B portal has been completed on time and was increased from 120m to 131.1m. The office/Laboratory has also been completed on time. The phase 2 mine development of 600m will commence this week and the Company is now discussing with Metso the ordering procedure and protocols for the long lead time crushing equipment. Metso are currently with members of the Almonty team in Portugal concluding the lock cycle process tests which will then enable Metso to finalize their engineering study of the flotation plant. The crushing engineering study was finalized 6 months ago.
Los Santos mine - With the increasing Tungsten prices in the past couple of weeks and the expected aggressive price increases expected in 2021 due to replenishments of inventories and a supply deficit, the Company is now preparing Los Santos to reactivate the tailings processing section of the plant. A recent report by the head of global commodities research at Goldman Sachs, Mr. Jeffrey Currie, on December 8th has merely added to our confidence in pricing in 2021.
Panasqueira mine – Production rates will be maintained in 2021 and this mine will continue to produce the highest-grade Wolframite available in the market backed by the highest recovery rate of any Tungsten gravity plant in the world. The sheer depth of Tungsten and Tin understanding contained in this project’s fifth generational team makes them the global leader in Tungsten/Tin expertise. This depth of knowledge has enabled the Company to approach our Sangdong project with a high degree of successful certainty and this was a deciding factor in KFW/Plansee supporting the build so convincingly.
Valtreixal – The permit process is on going as foreseen, but regrettably the Covid crisis in Spain has slowed the progress. We now expect a further 3 months' delay until permits are finalized. However, given its low operational cost and extremely high tin content (30%), Valtreixal will be a much welcomed addition to our portfolio once operational.
Almonty Korea Moly project – Now that the financing has concluded for Almonty Korea Tungsten, the Company can turn its attention to converting the historical data of the resource into a 43-101 compliant instrument with drilling scheduled for early 2021. With only 150m separating the Moly deposit from our existing infrastructure, the drill program will be extremely cost-effective. Our reported numbers of 16.3mt at 0.40% Mo are quoted with a 40% reduction which is applied when confirmation drilling has not confirmed the historical data.
The Company believes once confirmation drilling is concluded, it will clearly demonstrate one of SE Asia’s largest Moly deposits in both longevity of approx 50 years and grade, and is easily accessible from the existing infrastruture. It is worth noting that South Korea is one of the largest consumers of Moly in the world mainly related to the steel business, and currently the vast majority of Mo is imported. There is considerable local support to see this resource developed as quickly as possible. This will further solidify our position as South Korea’s largest mining company.
Almonty Corporate - During the run-up and closing of the KFW financing, the Company had to provide a snapshot of the Company to the lender. This meant that all previous strategies of growth through acquisition had to remain on hold. Normally, this is not an issue, but given how long the closing took, the Company has not been active for some time. Now that the KFW execution has occurred, the Company can resume its growth approach to continually increase our Tungsten/Moly footprint, as strategic metals continue to gain importance across the world with multiple private companies now looking to stockpile.
Almonty’s Chairman, President and CEO Lewis Black commented:
“With the successful execution of the KFW loan, we can now go back to our continuing growth not just from building the world’s largest Tungsten project but also to look at our 100% owned Moly deposit and if other viable acquisitions are matched to our strategy.
“We have received multiple inquiries from shareholders regarding the final makeup of the ownership structure and Board composition after financial close of the KFW US$75.1m debt financing. The Plansee group will not become a control person which is triggered at a 20% ownership and will have one seat of a six-person Board. The role of Chairman, President and CEO will remain unchanged and I will also remain the second largest shareholder, merely swapping places with GTP/Plansee from the largest to the second. Given the importance of the Sangdong project to the Plansee Group supply chain and, in turn, to their customers, it is important to both the Plansee Group and to Almonty that they sit on our Board.
“I wish all of our shareholders and customers a Happy Christmas and look forward to an incredible 2021.”
About Almonty
The principal business of Toronto, Canada-based Almonty Industries Inc. is the mining, processing and shipping of tungsten concentrate from its Los Santos mine in western Spain and its Panasqueira mine in Portugal as well as the development of its Sangdong tungsten mine in Gangwon Province, South Korea and the development of the Valtreixal tin/tungsten project in north western Spain. The Los Santos mine was acquired by Almonty in September 2011 and is located approximately 50 kilometres from Salamanca in western Spain and produces tungsten concentrate. The Panasqueira mine, which has been in production since 1896, located approximately 260 kilometres northeast of Lisbon, Portugal, was acquired in January 2016 and produces tungsten concentrate.
The Sangdong mine, which was historically one of the largest tungsten mines in the world and one of the few long-life, high-grade tungsten deposits outside of China, was acquired in September 2015 through the acquisition of a 100% interest in Woulfe Mining Corp. Almonty owns 100% of the Valtreixal tin-tungsten project in north western Spain. Further information about Almonty’s activities may be found at www.almonty.com and under Almonty’s SEDAR profile at www.sedar.com.
Outstanding Shares
172,008,906
02/26/2021
WE SIMPLY NEEDED TO FIND A BOTTOM AFTER THE "PARTY", THE "SPIKE."
The bigger the spike, the bigger the hangover.
ETF MJ
These are the lows we want to see thru the end of the year.
POTX 13.91
THCX 16.55
HMLSF 8.46
MJO 86.24
YOLO 21.12
CNBS 25.40
MJ 19.51
MSOS 40.80
Just looked at the forecast - Wed +1
Lol, ok - whoever's strain of weed your samplin' - BUY MORE! ;)
If sarcasm (which is always tricky) Loop Insights [for both]
If none of the above, these are popular
https://www.mentalfloss.com/article/23706/10-pop-culture-elephants-plus-4-reasonable-facsimiles
No, the elephants.
?.. of the tickers?..
Names would be handy.
Yw, not a God but still comes in handy ;)
I think it will be a good year for
RACMF
MTRX.v
That is amazing! Thank you for sharing
Yuuuup! Sold some today to buy Khiron. Mexico is legalizing both recreational and medical in April. Vicente Fox was on Bloomberg today.
Doesn't meet your criteria, but I like low cost plays like SPONF. Currently a 4 bagger for me. Allows me to buy enough shares so that I actually have enough position to meaningfully trade around it.
"Hello John,
I wish it is what you have been looking for ;)
If you have any doubt, do not hesitate to contact me
Thank you for your email and for using the App!
Albert"
Hello, I recently discovered STOCKS ALERT and can’t wait to try it on my Samsung Galaxy Z fold2 cell phone.
If all indications are correct, this is exactly what I have been looking for. I currently use Fidelity stock “alerts” for price targets.
I have been looking for an alert system for stocks hitting RSI(14) targets. If this is as good as I think it is, I will promote this program!
Personal website
Investment newsletter
Social Media sites
ZOOM discussion group
Meetup.com
Etc.
Thank you,
JohnCM
California
I looked for and found a new app for my android device.
STOCKS ALERT
ver 2.0.0.26
Milhomens Apps
milhomens.apps@gmail.com
I have known of this discipline for 30+ years, but rarely use it, UNTIL NOW!
"Trading around a core position"
You own 100 shares of ABC Inc.
You have STOCKS ALERT setup on your phone with your portfolio. All of your stocks are monitored for RSI(14) oversold (30) and overbought (70) levels. As well as (20), (80), (60).
When ABC Inc. flashes the RSI(14) 80 threshold, I sell 33 shares. When the stock flashes (60), I either, pocket the extra CASH or buy 33+ shares.
POTX has been a good one for me. Was a 4 bagger a week ago but it gave back an entire bag and change on the current dip. I'd like it a lot more if they'd reallocate the ACB portion.
CANNABIS ETF
Symbol Last Price
HMLSF
11.79
-0.41-3.39%
MJO
132.09
-4.46-3.27%
YOLO
27.66
-0.86-3.03%
CNBS
34.95
-1.01-2.81%
MJ
25.50
-1.41-5.24%
MSOS
51.73
-1.21-2.29
LOL!, bitchin' bitch ;).
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |